Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Merck
Merck
What Bill Gates Says About Drug Companies
Forbes
Thu, 11/10/11 - 12:24 pm
Bill Gates
GSK
vaccines
philanthropy
Merck
Sanofi
Merck & Co launches long-acting birth control implant Nexplanon
Yahoo/AP
Wed, 11/9/11 - 11:33 am
Merck
birth control
Nexplanon
contraceptives
Study: Deal terms getting richer as pharmas stockpile antibody tech
Fierce Biotech
Tue, 11/8/11 - 11:06 am
antibodies
autoimmune disease
CNS
Roche
AstraZeneca
Bristol-Myers Squibb
Novartis
Pfizer
Merck
mAb
Dendreon, Merck's Hepatitis C Drug: Future Prospects Look Encouraging
Seeking Alpha
Mon, 11/7/11 - 09:25 am
Merck
Dendreon
hepatitis C
Victrelis
FDA panel backs expanded use of Merck's Vytorin
Yahoo/AP
Thu, 11/3/11 - 08:50 am
FDA
Merck
Vytorin
kidney disease
One Pill Makes You Stronger: Pfizer Earnings Bring Strength To Your Portfolio
Seeking Alpha
Wed, 11/2/11 - 11:22 am
earnings
Merck
Pfizer
Ranking Drug Company Dividend Stocks By Risk And Growth
Seeking Alpha
Tue, 11/1/11 - 06:14 pm
dividends
JNJ
Pfizer
Novartis
GSK
Merck
Sanofi
Abbott Laboratories
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
5 One-Drug Wonders Going for No. 2
Motley Fool
Tue, 11/1/11 - 11:09 am
Dendreon
Provenge
DN24-02
Elan
Tysabri
bapineuzumab
ONYX Pharmaceuticals
Bayer
regorafenib
Carfilzomib
Nexavar
Vertex
Merck
Incivek
Kalydeco
Momenta
Lovenox
Copaxone
Teva Pharmaceuticals
Merck's Penance Has Gone On Long Enough
Investopedia
Tue, 11/1/11 - 08:55 am
Merck
Alexion
Forest Labs
JNJ
Gilead
Eli Lilly
Novartis
Pfizer
Vertex
Melbourne woman leads Australian class action on cancer vaccine Gardasil
Herald Sun, Australia
Mon, 10/31/11 - 11:40 am
Australia
Class Action Lawsuit
Merck
HPV
Gardasil
Merck Can Block Teva on Generic Temodar as Court Rejects Appeal
Bloomberg
Mon, 10/31/11 - 11:28 am
Teva Pharmaceuticals
generics
Temodar
Merck
brain cancer
FDA Gives Favorable Review to SHARP Ahead of Vytorin Advisory Panel
Forbes
Mon, 10/31/11 - 10:51 am
Vytorin
Merck
FDA
advisory panels
SHARP
Merck Sells Its Interest in Johnson & Johnson-Merck Consumer Pharmaceuticals
Benzinga
Sun, 10/30/11 - 12:44 pm
Merck
JNJ
Vertex Bests Merck in New Hepatitis C Drug Sales
NY Times, NY
Sat, 10/29/11 - 12:55 pm
hepatitis C
Merck
Vertex
Incivek
Victrelis
Merck’s Vytorin Cuts Heart Risk in Kidney Patients, FDA Says
Bloomberg
Sat, 10/29/11 - 12:46 pm
FDA
Vytorin
Merck
kidney disease
Merck Profit Tops Analyst Estimates on Diabetes Drug Sales
Bloomberg
Fri, 10/28/11 - 09:37 am
Merck
earnings
Vertex A Steal Based On Blockbuster Hepatitis C Drug Sales
Seeking Alpha
Fri, 10/28/11 - 09:34 am
Vertex
earnings
hepatitis C
Bristol-Myers Squibb
JNJ
Eli Lilly
Merck
SciClone
Pharmasset
Gardasil Policy May Grow Coverage Without Reversing Sales Slide
Bloomberg Businessweek
Thu, 10/27/11 - 11:11 am
HPV
Merck
Gardasil
Earnings Preview: Merck reports on third quarter
Yahoo/AP
Wed, 10/26/11 - 06:12 pm
earnings
Merck
Biotech 2011: Teva, Merck directors share views of biopharma industry
Med City
Wed, 10/26/11 - 11:07 am
Teva Pharmaceuticals
Merck
Biotech 2011
Pages
« first
‹ previous
…
150
151
152
153
154
155
156
157
158
…
next ›
last »